Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer 1988 2019

Filtrer
Tidsskriftartikel
2019

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm A single-case report

Iversen, K. F., Holdgaard, P. C., Preiss, B., Nyvold, C. G. & Plesner, T., sep. 2019, I : Haematologica. 104, 9, s. e432-e433

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

MAIA Trial Investigators, 30. maj 2019, I : New England Journal of Medicine. 380, 22, s. 2104-2115

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Control Groups
Confidence Intervals
Neutropenia
daratumumab
Lymphopenia
81 Downloads (Pure)

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Adams, H. C., Stevenaert, F., Krejcik, J., Van der Borght, K., Smets, T., Bald, J., Abraham, Y., Ceulemans, H., Chiu, C., Vanhoof, G., Usmani, S. Z., Plesner, T., Lonial, S., Nijhof, I., Lokhorst, H. M., Mutis, T., van de Donk, N. W. C. J., Sasser, A. K. & Casneuf, T., 1. mar. 2019, I : Cytometry. Part A. 95, 3, s. 279-289

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Granzymes
Flow Cytometry
Population
Immunophenotyping
Plasma Cells

Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Usmani, S. Z., Nahi, H., Mateos, M-V., van de Donk, N. W. C. J., Chari, A., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Liu, K. & San Miguel, J., 22. aug. 2019, I : Blood. 134, 8, s. 668-677

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Hyaluronoglucosaminidase
Pharmacokinetics
Enzymes
daratumumab
Safety
2018
70 Downloads (Pure)

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Yan, X., Clemens, P. L., Puchalski, T., Lonial, S., Lokhorst, H., Voorhees, P. M., Usmani, S., Richardson, P. G., Plesner, T., Liu, K., Orlowski, R. Z., Losic, N., Jansson, R., Ahmadi, T., Lantz, K., Ruixo, J. J. P., Zhou, H. & Xu, X. S., 2018, I : Clinical Pharmacokinetics. 57, 4, s. 529-538

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
daratumumab
Albumins
Odds Ratio
Confidence Intervals
Kidney
2017
124 Downloads (Pure)

Clinical Implications of Complex Pharmacokinetics for Daratumumab Dose Regimen in Patients With Relapsed/Refractory Multiple Myeloma

Xu, X. S., Yan, X., Puchalski, T., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Plesner, T., Liu, K., Khan, I., Jansson, R., Ahmadi, T., Perez Ruixo, J. J., Zhou, H. & Clemens, P. L., 2017, I : Clinical Pharmacology & Therapeutics. 101, s. 721-724

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Pharmacokinetics
Pharmaceutical Preparations
daratumumab

Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma

Casneuf, T., Xu, X. S., Adams, H. C., Axel, A. E., Chiu, C., Khan, I., Ahmadi, T., Yan, X., Lonial, S., Plesner, T., Lokhorst, H. M., van de Donk, N. W. C. J., Clemens, P. L. & Sasser, A. K., 2017, I : Blood Advances. 1, 23, s. 2105-2114

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Safety
daratumumab
Infection Control
Clinical Trials
Neoplasms

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study

Sezer, O., Beksac, M., Hajek, R., Sucak, G., Cagirgan, S., Linkesch, W., Meltem Akay, O., Gülbas, Z., Nahi, H., Plesner, T., Snowden, J. A., Timurağaoğlu, A., Dechow, T., Lang, A., Tuğlular, T., Drach, J., Armbrecht, G., Potamianou, A., Couturier, C., Olie, R. A. & 3 flere, Feys, C., Allietta, N. & Terpos, E., jul. 2017, I : British Journal of Haematology. 178, 1, s. 61-71

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Observation
Peripheral Nervous System Diseases
Bone Density
Disease-Free Survival
Bortezomib

Monocytes and granulocytes reduce CD38 expression levels on myeloma cells in patients treated with daratumumab

Krejcik, J., Frerichs, K. A., Nijhof, I. S., van Kessel, B., van Velzen, J., Bloem, A. C., Broekmans, M., Zweegman, S., van Meerloo, J., Musters, R. J., Poddighe, P., Groen, R., Chiu, C., Plesner, T., Lokhorst, H. M., Sasser, A. K., Mutis, T. & van de Donk, N. W. C. J., 2017, I : Clinical Cancer Research. 23, 24, s. 7498-7511

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

daratumumab
Membrane Proteins
Cell Membrane
In Vitro Techniques
80 Downloads (Pure)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Withofs, N., Caers, J., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S. & 2 flere, Durie, B. & Terpos, E., 2017, I : Blood Cancer Journal. 7, 8, 6 s., e599.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Surveys and Questionnaires
Skeleton
Positron Emission Tomography Computed Tomography
2016

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

van de Donk, N. W. C. J., Moreau, P., Plesner, T., Palumbo, A., Gay, F., Laubach, J. P., Malavasi, F., Avet-Loiseau, H., Mateos, M-V., Sonneveld, P., Lokhorst, H. M. & Richardson, P. G., 11. feb. 2016, I : Blood. 127, 6, s. 681-695

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Plasma Cells
Disease-Free Survival
Pharmaceutical Preparations
daratumumab
elotuzumab

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

Usmani, S. Z., Weiss, B. M., Plesner, T., Bahlis, N. J., Belch, A., Lonial, S., Lokhorst, H. M., Voorhees, P. M., Richardson, P. G., Chari, A., Sasser, A. K., Axel, A., Feng, H., Uhlar, C. M., Wang, J., Khan, I., Ahmadi, T. & Nahi, H., 23. maj 2016, I : Blood. 128, 1, s. 37-44

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Confidence Intervals
Proteasome Inhibitors
Disease-Free Survival
Safety
daratumumab
325 Downloads (Pure)

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Dimopoulos, M. A., Oriol, A., Nahi, H., San-Miguel, J., Bahlis, N. J., Usmani, S. Z., Rabin, N., Orlowski, R. Z., Komarnicki, M., Suzuki, K., Plesner, T., Yoon, S-S., Ben Yehuda, D., Richardson, P. G., Goldschmidt, H., Reece, D., Lisby, S., Khokhar, N. Z., O'Rourke, L., Chiu, C. & 5 flere, Qin, X., Guckert, M., Ahmadi, T., Moreau, P. & POLLUX Investigators, 6. okt. 2016, I : The New England Journal of Medicine. 375, 14, s. 1319-1331

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Control Groups
Disease-Free Survival
Residual Neoplasm
Confidence Intervals
Neutropenia

Daratumumab depletes CD38+ immune-regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Krejcik, J., Casneuf, T., Nijhof, I. S., Verbist, B., Bald, J., Plesner, T., Syed, K., Liu, K., van de Donk, N. W. C. J., Weiss, B. M., Ahmadi, T., Lokhorst, H. M., Mutis, T. & Sasser, A. K., 24. maj 2016, I : Blood. 128, 3, s. 384-394

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

T-Cell Antigen Receptor
Immunosuppressive Agents
Regulatory B-Lymphocytes
CD4-CD8 Ratio
daratumumab

Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

Mateos, M-V., Granell, M., Oriol, A., Martínez-López, J., Bladé, J., Hernandez, M. T., Martín, J., Gironella, M., Lynch, M., Bleickardt, E., Paliwal, P., Singhal, A., San-Miguel, J. & Plesner, T., nov. 2016, I : British Journal of Haematology. 175, 3, s. 448-456 9 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Safety
Disease-Free Survival
elotuzumab
Survival Rate
Population

Facilitated subcutaneous immunoglobulin administration (fSCIg): a new treatment option for patients with secondary immune deficiencies

Blau, I-W., Conlon, N., Petermann, R., Nikolov, N. & Plesner, T., jul. 2016, I : Expert Review of Clinical Immunology. 12, 7, s. 705-11

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Hematologic Neoplasms
Survival Rate

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Eichhorst, B., Fink, A-M., Bahlo, J., Busch, R., Kovacs, G., Maurer, C., Lange, E., Köppler, H., Kiehl, M., Sökler, M., Schlag, R., Vehling-Kaiser, U., Köchling, G., Plöger, C., Gregor, M., Plesner, T., Trneny, M., Fischer, K., Döhner, H., Kneba, M. & 7 flere, Wendtner, C-M., Klapper, W., Kreuzer, K-A., Stilgenbauer, S., Böttcher, S., Hallek, M. & The German CLL Study group (GCLLSG), 20. maj 2016, I : The Lancet Oncology. 17, 7, s. 928-942

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

B-Cell Chronic Lymphocytic Leukemia
diaziquone
Disease-Free Survival
Poisons
fludarabine

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Zweegman, S., van der Holt, B., Mellqvist, U-H., Salomo, M., Bos, G. M. J., Levin, M-D., Visser-Wisselaar, H., Hansson, M., van der Velden, A. W. G., Deenik, W., Gruber, A., Coenen, J. L. L. M., Plesner, T., Klein, S. K., Tanis, B. C., Szatkowski, D. L., Brouwer, R. E., Westerman, M., Leys, M. R. B. L., Sinnige, H. A. M. & 8 flere, Haukås, E., van der Hem, K. G., Durian, M. F., Mattijssen, E. V. J. M., van de Donk, N. W. C. J., Stevens-Kroef, M. J. P. L., Sonneveld, P. & Waage, A., 3. mar. 2016, I : Blood. 127, 9, s. 1109-16

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Melphalan
Prednisone
Confidence Intervals
Disease-Free Survival
Maintenance
110 Downloads (Pure)

Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference

McCudden, C., Axel, A. E., Slaets, D., Dejoie, T., Clemens, P. L., Frans, S., Bald, J., Plesner, T., Jacobs, J. F. M., van de Donk, N. W. C. J., Moreau, P., Schecter, J. M., Ahmadi, T. & Sasser, A. K., 1. jun. 2016, I : Clinical Chemistry and Laboratory Medicine. 54, 6, s. 1095-104

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Monoclonal Antibodies
Electrophoresis
Monitoring
Assays
daratumumab

Multiplex polymerase chain reaction-based prognostic models in diffuse large B-cell lymphoma patients treated with R-CHOP

Green, T. M., Jensen, A. K., Holst, R., Falgreen, S., Bøgsted, M., de Stricker, K., Plesner, T., Mourits-Andersen, H. T., Frederiksen, M., Johnsen, H. E., Pedersen, L. M. & Møller, M. B., 16. maj 2016, I : British Journal of Haematology. 174, 6, s. 876-886

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Lymphoma, Large B-Cell, Diffuse
Multiplex Polymerase Chain Reaction
Vincristine
Prednisone
Disease-Free Survival
90 Downloads (Pure)

Patient pools and the use of "patient means" are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay

Hinge, M., Lund, E. D., Brandslund, I., Plesner, T. & Madsen, J. S., 2016, I : Clinical Chemistry and Laboratory Medicine. 54, 3, s. 403-406

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Åben adgang
Fil
Quality control
Alkaline Phosphatase
Assays
Bone
Biochemistry

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Plesner, T., Arkenau, H-T., Gimsing, P., Krejcik, J., Lemech, C., Minnema, M. C., Lassen, U., Laubach, J. P., Palumbo, A., Lisby, S., Basse, L., Wang, J., Sasser, A. K., Guckert, M. E., de Boer, C., Khokhar, N. Z., Yeh, H., Clemens, P. L., Ahmadi, T., Lokhorst, H. M. & 1 flere, Richardson, P. G., 16. aug. 2016, I : Blood. 128, s. 1821-28

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Safety
Proteasome Inhibitors
Alkylating Agents
daratumumab
Neutropenia

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Moreau, P., van de Donk, N. W. C. J., San Miguel, J., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P. & Mateos, M-V., maj 2016, I : Drugs. 76, 8, s. 853-67

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

daratumumab
Clinical Trials

Prophylactic immunoglobulin therapy in secondary immune deficiency: an expert opinion

Agostini, C., Blau, I-W., Kimby, E. & Plesner, T., sep. 2016, I : Expert Review of Clinical Immunology. 12, 9, s. 921-6

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Expert Testimony
Guidelines
Physicians
2015

High-dose therapy improved the bone remodelling compartment canopy and bone formation in multiple myeloma

Hinge, M., Delaissé, J-M., Plesner, T., Clasen-Linde, E., Salomo, M. & Levin Andersen, T., 2015, I : British Journal of Haematology. 171, 3, s. 355–365

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Osteogenesis
Melphalan
Plasma Cells

Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy

Al-Zuhairy, A., Schrøder, H. D., Plesner, T., Abildgaard, N. & Sindrup, S. H., 2015, I : Journal of the Neurological Sciences. 349, 1-2, s. 60-64

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Peripheral Nervous System Diseases
Waldenstrom Macroglobulinemia
Skin
Myelin Sheath
Myeloma Proteins

Monoclonal antibodies in myeloma

Sondergeld, P., van de Donk, N. W. C. J., Richardson, P. G. & Plesner, T., 2015, I : Clinical Advances in Hematology & Oncology. 13, 9, s. 599-609

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., van de Donk, N., Ahmadi, T., Khan, I., Uhlar, C. M., Wang, J., Sasser, A. K., Losic, N., Lisby, S., Basse, L., Brun, N. & 1 flere, Richardson, P. G., 2015, I : The New England Journal of Medicine. 373, 13, s. 1207-1219

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

2014

Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer

Søe, K., Delaissé, J-M., Jakobsen, E. H., Hansen, C. & Plesner, T., 2014, I : Acta Oncologica. 53, 4, s. 547-556

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

zoledronic acid
Creatinine
Alkaline Phosphatase
Phase II Clinical Trials
Collagen Type I

European perspective on multiple myeloma treatment stratgies in 2014

Ludwig, H., Sonneveld, P., Davies, F., Bladé, J., Boccadoro, M., Cavo, M., Morgan, G., de la Rubia, J., Delforge, M., Dimopoulos, M., Einsele, H., Facon, T., Goldschmidt, H., Moreau, P., Nahi, H., Plesner, T., San-Miguel, J., Hajek, R., Sondergeld, P. & Palumbo, A., 2014, I : Oncologist. 19, 8, s. 829-44

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Pharmaceutical Preparations
Drug Combinations
Comorbidity
Clinical Studies

Safety and efficacy of daraturmumab with lenalidomide and dexamethasone in relapsed or relapsed, refactory multiple myeloma

Plesner, T., Arkenau, H-T., Lokhorst, H. M., Gimsing, P., Krejcik, J., Rose Lemech, C., Minnema, M., Lassen, U. N., Laubach, J., Ahmadi, T., Yeh, H., Guckert, M., Feng, H., C. Brun, N., Lisby, S., Basse, L., Palumbo, A. & Richardson, P. G., 2014, I : Journal of Clinical Oncology. 124, 21

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network

van de Donk, N. W. C. J., Palumbo, A., Johnsen, H. E., Engelhardt, M., Gay, F., Gregersen, H., Hajek, R., Kleber, M., Ludwig, H., Morgan, G., Musto, P., Plesner, T., Sezer, O., Terpos, E., Waage, A., Zweegman, S., Einsele, H., Sonneveld, P., Lokhorst, H. M. & European Myeloma Network, jun. 2014, I : Haematologica. 99, 6, s. 984-96

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Plasma Cells
Clone Cells
Waldenstrom Macroglobulinemia
Lymphoproliferative Disorders
Bone Fractures
2013

A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma

Plesner, T., 2013, I : British Journal of Haematology. 163, 3, s. 334-342

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

Popat, R., Plesner, T., Davies, F., Cook, G., Cook, M., Elliott, P., Jacobson, E., Gumbleton, T., Oakervee, H. & Cavenagh, J., 2013, I : British Journal of Haematology. Supplement. 160, 5, s. 714-7

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia

Birgens, H. S., Frederiksen, H., Hasselbalch, H. C., Rasmussen, I. H., Nielsen, O., Kjeldsen, L., Larsen, H., Mourits-Andersen, T., Plesner, T., Rønnov-Jessen, D., Vestergaard, H., Klausen, T. W. & Schöllkopf, C., nov. 2013, I : British Journal of Haematology. 163, 3, s. 393-9 7 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Glucocorticoids
Hypersensitivity

Daratumumab:Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma

Richardson, P., Lokhorst, H., Palumbo, A., Nahi, H., Laubach, J., Gimsing, P., Lisby, S., Cakana, A., Brun, NC. & Plesner, T., 2013, I : Drugs of the Future. 38, 8, s. 545-554

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Is retention of zoledronic acid onto bone different in multiple myeloma and breast cancer patients with bone metastasis?

Søe, K., Plesner, T., Jakobsen, E. H., Hansen, C. T., Jørgensen, H. B. & Delaissé, J-M., aug. 2013, I : Journal of Bone and Mineral Research. 28, 8, s. 1738-50 13 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

zoledronic acid
Alkaline Phosphatase
Linear Models
Regression Analysis
Phase II Clinical Trials

Rituximab and Dexamethasone vs Dexamethasone Monotherapy in Newly Diagnosed Patients with Primary Immune Thrombocytopenia

Gudbrandsdottir, S., Birgens, H. S., Frederiksen, H., Jensen, B. A., Jensen, M. K., Kjeldsen, L., Klausen, T. W., Larsen, H., Mourits-Andersen, H. T., Nielsen, C. H., Nielsen, O. J., Plesner, T., Pulczynski, S., Rasmussen, I. H., Rønnov-Jessen, D. & Hasselbalch, H. C., 14. mar. 2013, I : Blood. 121, 11, s. 1976-1981

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Idiopathic Thrombocytopenic Purpura
Platelet Count
Incidence
2012

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 8 flere, Ben Yehuda, D., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C., Dimopoulos, M. A. & MM-015 Investigators, 2012, I : The New England Journal of Medicine. 366, 19, s. 1759-69

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Melphalan
Prednisone
Multicenter Studies
Placebos
Maintenance

Treatment with bortezomib in multiple myeloma is associated with only a transient and brief increase of bone specific alkaline phosphatase

Haidl, F., Plesner, T. & Lund, T., 2012, I : Leukemia Research. 36, 10, s. 1296-1299

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Alkaline Phosphatase
zoledronic acid
Anabolic Agents
Bortezomib
2011

Anti-myelin associated glycoprotein neuropathy responding to lenalidomide

Larsen, L. H., Lund, T., Vilholm, O. J. & Plesner, T., 2011, I : Acute Myeloid Leukemia Research Today. 35, 11, s. e198-9

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Pfreundschuh, M., Kuhnt, E., Trümper, L., Osterborg, A., Trneny, M., Shepherd, L., Gill, D. S., Walewski, J., Pettengell, R., Jaeger, U., Zinzani, P-L., Shpilberg, O., Kvaloy, S., Brown, P. D. N., Stahel, R., Milpied, N., López-Guillermo, A., Poeschel, V., Grass, S., Loeffler, M. & 3 flere, Murawski, N., MabThera International Trial (MInT) Group & Plesner, T., 2011, I : The Lancet Oncology (Czech Edition). 12, 11, s. 1013-1022

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone

Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

Ludwig, H., Beksac, M., Bladé, J., Cavenagh, J., Cavo, M., Delforge, M., Dimopoulos, M., Drach, J., Einsele, H., Facon, T., Goldschmidt, H., Harousseau, J-L., Hess, U., Kropff, M., Leal da Costa, F., Louw, V., Magen-Nativ, H., Mendeleeva, L., Nahi, H., Plesner, T. & 5 flere, San-Miguel, J., Sonneveld, P., Udvardy, M., Sondergeld, P. & Palumbo, A., 2011, I : Oncologist. 16, 4, s. 388-403

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Bortezomib
2010

Current multiple myeloma treatment strategies with novel agents: a European perspective

Ludwig, H., Beksac, M., Bladé, J., Boccadoro, M., Cavenagh, J., Cavo, M., Dimopoulos, M., Drach, J., Einsele, H., Facon, T., Goldschmidt, H., Harousseau, J-L., Hess, U., Ketterer, N., Kropff, M., Mendeleeva, L., Morgan, G., Palumbo, A., Plesner, T., San Miguel, J. & 4 flere, Shpilberg, O., Sondergeld, P., Sonneveld, P. & Zweegman, S., 1. jan. 2010, I : Oncologist. 15, 1, s. 6-25 19 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Melphalan
Vincristine
Prednisone
Cytogenetics
Comorbidity

Effect of withdrawal of zoledronic acid treatment on bone remodelling markers in multiple myeloma

Lund, T., Abildgaard, N., Delaisse, J-M. & Plesner, T., 1. okt. 2010, I : British Journal of Haematology. 151, 1, s. 92-3 2 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Osteoblasts
Glucocorticoids
Bortezomib
In Vitro Techniques
Collagen Type I
Collagen Type I
Alkaline Phosphatase
Serum
Osteogenesis
Matrix Metalloproteinases
Hybrid Cells
Osteoclasts
Osteoblasts
Cellular Microenvironment
Cell Fusion

Potential of Resveratrol Analogues as Antagonists of Osteoclasts and Promoters of Osteoblasts

Kupisiewicz, K., Boissy, P., Abdallah, B. M., Hansen, F. D., Erben, R. G., Savouret, J-F., Søe, K., Levin Andersen, T., Plesner, T. & Delaisse, J-M., 15. sep. 2010, I : Calcified Tissue International. 87, 5, s. 437-449

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Osteoclasts
Osteoblasts
Cell Proliferation
Ovariectomy
In Vitro Techniques
2009

A physical mechanism for coupling bone resorption and formation in adult human bone

Andersen, T. L., Søndergaard, T. E., Skorzynska, K., Dagnaes-Hansen, F., Plesner, T. L., Hauge, E. M., Plesner, T. & Delaisse, J-M., 1. jan. 2009, I : American Journal of Pathology. 174, 1, s. 239-47 8 s.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Osteoclasts
Osteoblasts
Osteogenesis